Skip to main content

Client News

Mainz Biomed expands corporate health program for ColoAlert with the addition of three new companies in Germany

4th April 2023

Destiny Pharma: Landmark data published on successful NTCD-M3 gut colonisation after fidaxomicin administration

4th April 2023

Carbios licensing documentation ready for worldwide industrial and commercial deployment of its PET biorecycling technology

3rd April 2023

Destiny Pharma: notice of full year results and investor presentation

3rd April 2023

ONWARD publishes first annual ESG summary

30th March 2023

Mainz Biomed reports positive results from feasibility study evaluating its portfolio of novel mRNA biomarkers for early detection of advanced colorectal adenomas

29th March 2023

Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need

29th March 2023

Newron presents six-month interim data from the first 100 patients randomized in study 014/015 at the 31st European Congress of Psychiatry

28th March 2023

ONWARD: convocation of the 2023 annual general meeting of shareholders and proposed resolutions

28th March 2023

ONWARD reports 2022 full year financial and operating results

28th March 2023